Schmidt & Clark | A National Law Firm

Lollipops & Lawsuits - Actiq Side Effects

Bookmark | Live Chat

Link to Article: Lollipops & Lawsuits - Actiq Side Effects

Posted in: Actiq

Questions are raised over how a potent painkiller has been marketed.

Source | Newsweek

May 7, 2007 issue - The fast-acting narcotic lollipop Actiq is FDA-approved for treating cancer pain, and cancer pain only. Patients are warned not to ingest more than 120 doses per month. Ed McAteer, however, does not have cancer, and in an average month he may suck on as many as 300 of the potent raspberry-flavored pops, a dosage so high and constant that its sugar content has corroded away all his teeth. “Actiq is the best thing I’ve ever tried,” he says. Anyone who didn’t know him might assume he was abusing the drug, and that his only prescription should be for rehab.

But McAteer, a soft-spoken 43-year-old, doesn’t take the drug to get high. It simply makes him “able to survive as a human being,” he says, dulling migraines so severe that even the odor of fresh-cut grass can set them off. His doctor, who regularly prescribes the drug to patients who don’t fit the FDA’s indications, is one of the nation’s top authorities on pain, Russ Portenoy of Beth Israel Medical Center in New York. Portenoy’s “off-label” prescribing is legal, and the drug is “safe and effective” for many patients, he says, whether they have cancer or not. So why is Actiq’s widespread off-label use at the heart of a major controversy?

When the FDA approved Actiq in 1998, it did so based on the only available studies, all done on cancer patients. Since then, the drug’s popularity has surged among both docs who don’t specialize in cancer and patients who don’t have it. As many as 80 percent of the 400,000 prescriptions written each year for Actiq and its generic versions (licensed by Actiq’s maker, Cephalon) go to sufferers of chronic, noncancer pain. There are no large, completely objective studies of Actiq’s effectiveness in these patients, but the drug’s active ingredient, fentanyl, has been used widely for more than 40 years. Docs of all stripes learn about fentanyl in medical school, and so, says John Osborn, Cephalon general counsel, they are comfortable with it.

But Cephalon, many critics charge, has itself grown too comfortable with the idea of docs’ prescribing its drug to noncancer patients—and according to an ongoing lawsuit and government probes, the company may have encouraged them to do so. Unlike off-label prescribing, off-label marketing is illegal. But it is not uncommon; nearly every major drug company in the United States has been investigated for the practice in the past few years.

Do I Have an Actiq Lawsuit?

If you or a loved one have taken Actiq and DO NOT HAVE CANCER (been prescribed Actiq “off-label”), become ADDICTED or suffered from any serious side effects including TOOTH DECAY or TOOTH LOSS, you should contact us immediately. You may be entitled to compensation and we can help.

Read More >>> Actiq Lawsuit Resource

Study finds 90 Percent of Actiq ‘Lollipop’ Prescriptions are Off-label

Bookmark | Live Chat

Link to Article: Study finds 90 Percent of Actiq ‘Lollipop’ Prescriptions are Off-label

Posted in: Actiq

Source | Prime Therapeutics LLC  

A recent Prime Therapeutics (Prime) study found significant patterns of “off-label” prescribing for Actiq(R) among patients taking the powerful painkilling “lollipop.” Prescribing Actiq according to FDA guidelines is important for patient safety reasons because of the drug’s serious side effects, including its addictive nature.

The results of the Prime study confirm concerns about the drug, which have been highlighted recently by the national news media. Prime, a thought leader in pharmacy benefit management, provides programs that manage the use of Actiq and other dangerous drugs in an effort to promote health and safety while ensuring that patients get the treatment they need.

“The FDA has only approved Actiq for use by cancer patients who are already taking a long-acting, chronic painkiller but suffer from severe spikes in pain,” stated Pat Gleason, PharmD, Director of Medical and Pharmacy Integration Services for Prime. “The Prime study, however, found that only slightly more than 10 percent of the patients receiving the drug over a three- month period in 2005 met those guidelines. Nearly 90 percent of Actiq prescriptions in our study were off-label, or not prescribed according to the guidelines set forth by the FDA.”

Actiq contains fentanyl, a known potent synthetic opioid with a high potential for abuse and overdose. In addition, fentanyl has been linked to fatal respiratory complications. As a result, while physicians are allowed to prescribe medications for unapproved or “off-label” use, the FDA recommends strict adherence to Actiq’s prescribing guidelines.

Last year, in response to the safety concerns highlighted in the study, Prime began offering programs to promote Actiq’s safe use. These programs include a monthly limit of 120-doses of Actiq, or a newer related drug, Fentora(R). Patients are also required to have prior authorization from their doctor and prescriptions are limited to a 12-month period. Prime’s program also encourages members to take a long-acting opioid for chronic pain. The program guidelines follow FDA recommendations.

“There are serious safety issues regarding Actiq, so doctors need to be careful how it is prescribed,” said Gleason. “Prime integrates pharmacy and medical data to identify misuse of drugs such as Actiq and then develops programs to ensure patient safety. Our drug utilization programs not only keep members safe, but save health plans thousands of dollars a month.”

The study analyzed Actiq patient claims from a Midwestern commercial health plan from April through June 2005. Of the 95 patients who received prescriptions for the lollipop during that time, only 21 had a diagnosis of cancer or AIDS. In addition, only 10 of those 21 patients were taking a long- acting opioid painkiller. Overall, 84 of the 95 Actiq prescriptions, nearly 90 percent, were for off-label purposes. The study also found that more than 15 percent of Actiq prescriptions were for more than the FDA’s recommended 120 lollipops per month, suggesting that some patients may be overusing the drug.

‘Off-label’ use of potent narcotic Actiq growing, raising concern

Bookmark | Live Chat

Link to Article: ‘Off-label’ use of potent narcotic Actiq growing, raising concern

Posted in: Actiq

Source | Wall Street Journal

While pregnant with her second child three years ago, Tiare Frontera suffered from bad migraines. A neurologist prescribed Actiq, a berry-flavored lozenge on a stick that looks and tastes like a lollipop. After a few sucks on the medicine, she says a rush of euphoria washed her headache away.

Soon, Frontera, who had struggled with addictions to milder narcotics, was consuming five Actiq lozenges a day. When she gave birth, her baby son was cranky and wouldn’t sleep. Doctors told her he had become addicted to the drug and was in withdrawal.

Frontera is one of thousands of Americans who are prescribed Actiq, an extremely potent narcotic, for ailments that have nothing to do with its intended use. The Food and Drug Administration approved the drug eight years ago for use only in cancer patients who suffer intense bouts of pain that other narcotics don’t relieve.

In the first half of this year, oncologists accounted for only 1 percent of the 187,076 Actiq prescriptions filled at retail pharmacies in the United States, according to Verispan, whose surveys of prescription-drug sales are widely used in the industry. Data gathered from a network of doctors by research firm ImpactRx between June 2005 and October 2006 suggest more than 80 percent of patients who use the drug don’t have cancer. Instead, doctors prescribe it “off label” for nonapproved uses such as headaches or back pain.

Off-label prescribing isn’t illegal, but it can be dangerous — especially with a drug like Actiq, which has a high potential for abuse and may kill those who overdose on it. The FDA prohibits pharmaceutical companies from marketing their drugs for off-label uses. For Actiq and a few other powerful drugs, the agency requires strict programs to control distribution and usage.

Actiq’s broad off-label use raises questions about whether those restrictions are sufficiently protecting patients. “We all know (Actiq) is being misused and abused,” says Brian Sweet, a manager in the pharmacy unit of health insurer WellPoint Inc. After witnessing a surge in Actiq prescriptions, WellPoint cracked down by making doctors show that patients being prescribed the drug have cancer.

Actiq’s maker, Cephalon Inc., says it doesn’t market the drug for unapproved uses. While acknowledging Actiq is widely used off-label, it says it can’t control how doctors prescribe the drug.

Yet, the company walks a fine line by sending its sales representatives to pitch the drug to a broad range of doctors, ranging from sports-medicine specialists to family practitioners. It gives these doctors coupons for free samples. Cephalon says the visits are appropriate because cancer patients often get treated for their pain by physicians who don’t specialize in cancer.

Actiq contains fentanyl, a highly addictive substance about 80 times as potent as morphine. Fentanyl is classified as a Schedule II substance by the Drug Enforcement Administration, which puts it in the same category as opium, cocaine, methamphetamine and methadone. Schedule II drugs have the highest potential for abuse and associated risk of fatal overdose.

Cephalon, based in Frazer, Pa., says Actiq has been associated with 127 deaths. Two of them involved children who confused the drug for candy. Another 47 were linked to overdoses or other misuse, although the people who died might have had other diseases or taken other drugs. In the remaining 78 cases, doctors found cancer was responsible for the death, the company says. Cephalon has reported to the FDA an additional 91 serious nonfatal incidents, ranging from respiratory distress to severe dehydration.

DOCTORS PITCHED

Stephen Leighton, a general practitioner in Winston-Salem, N.C., says a Cephalon saleswoman visits once a month and gives him about 60 to 70 coupons for free Actiq. Patients can trade each coupon for six Actiq sticks. Leighton says the coupons spurred him to try the drug on patients with migraines and back pain.

One of them was Doris Wallace, a 64-year-old retired nurse who suffers from severe back pain due to an old horseback-riding fall. Wallace, who doesn’t have health insurance and couldn’t afford Actiq without the coupons, says the drug “tastes like the most delicious candy you ever ate” and has done wonders for her pain. At the height of her use, she was consuming 24 Actiq sticks a month.

The positive experience of patients like Wallace has led Leighton to prescribe Actiq more widely for different types of pain. Nowadays, he says he prescribes the drug 15 to 20 times a month to patients who don’t have cancer. If not for the free coupons, “I’d probably have been much less inclined to explore its use for a diverse range of pain management,” says Leighton, who says he treats at most three cancer patients at any given time.

Actiq also has surfaced on the streets of cities like Philadelphia, earning the nickname “perc-a-pop.” Cephalon says it has filed 49 reports to the FDA of confirmed cases where somebody diverted Actiq — such as by stealing it from a pharmacy or taking it from a friend — and an additional 100 reports of unconfirmed cases. Most are the result of pharmacy break-ins and need to be put in the context of the more than 200 million sticks of Actiq that have been sold.

Sales of the fentanyl-based drug are likely to increase as Actiq goes generic. In late September, Barr Pharmaceuticals Inc. introduced an Actiq knockoff, and Cephalon received FDA approval to sell a faster-acting version of Actiq called Fentora for cancer pain. Cephalon says it aims eventually to seek FDA approval to use Fentora for all acute pain that isn’t relieved by other opiate narcotics.

Do I Have An Actiq Lawsuit?

If you or a loved one have taken Actiq and become addicted to the drug or suffered from any serious side effects, you should contact us immediately. You may be entitled to compensation and we can help.

Free Confidential Case Evaluation >>> Actiq Lawyer

Small package, big problem

Bookmark | Live Chat

Link to Article: Small package, big problem

Posted in: Actiq

Source | The Salt Lake Tribune

Tastes like candy, packs a wallop — Actiq, a Utah-made painkiller, is called a blessing by many, but police and regulators warn of a possible darker side.

For those in the throes of the searing pain of late-stage cancer, Actiq, a Utah-made painkiller on a stick, brings quick, euphoric relief.
   
But for the very reason the fruit-flavored, lollipop-like narcotic is acclaimed - it is 80 times more potent than morphine - Actiq has come under scrutiny by law enforcement and the medical profession because of its addictive nature and unprescribed, or even illicit, use.

Steve Shoemaker oversaw clinical trials for the solid, orally dissolved form of the opioid fentanyl at what was then Anesta Corp. in the late 1990s - and he still remembers the payoff. The tearful gratitude of agonized patients relieved by just a few sucks on the painkiller.

“We called it the ‘Actiq Hug,’ ” says Shoemaker, who works for a small Florida medical consulting firm. “Doctors, even [drug] sales representatives, were getting hugged by cancer patients.

“One told me, ‘My pain used to control me, now I can control my pain.’ For severe chronic pain, that is a matter of quality of life.”

Anesta was acquired by pharmaceutical giant Cephalon in 2000, and in the years since, Actiq has become a huge profit center, while also becoming a leading “off-label” prescription, or a drug prescribed for other than its government-designated use. An estimated 80 percent of users of the extremely potent narcotic suffer from maladies other than cancer, the only usage approved by the Food and Drug Administration in 1998.

In fact, in the battle to get the drug approved, the FDA required that Actiq be marketed only to oncologists and their associates, and it mandates that Cephalon report quarterly whether there is potential for off-label usage greater than 15 percent. In a recent report in The Wall Street Journal, Cephalon officials argued that it is difficult to prove a prescription is inappropriate because cancer patients may visit many types of doctors to treat their pain and ailments.

Although the FDA’s restrictions on Actiq remain in force, they amount to little more than a prohibition on actively marketing products for off-label use.

Otherwise, they are advisory in nature. Doctors can legally prescribe Actiq for other types of pain and regularly do, with severe backaches and migraines favorite targets.

In The Wall Street Journal report, Verispan, whose surveys of prescription-drug sales are widely used in the industry, data for the first half of 2006 show that two specialties exceed 15 percent of Actiq prescriptions - anesthesiologists at 29.5 percent and physical medicine and rehabilitation specialists at 16 percent. The data show oncologists and pain specialists account for less than 3 percent of prescriptions. Cephalon doesn’t dispute the data.

The FDA won’t comment on the issue beyond promising enforcement actions against companies that cross the off-label promotional line. But within the medical community, the practice of off-label drug prescription is cause for debate.

“It’s important to remember that despite the FDA indication [for use], Actiq was intended for chronic pain, cancer-caused or not,” Shoemaker says. “Misunderstanding this is a frustration I have. Actiq has since been used in millions and millions of doses without a serious safety issue.”

Salt Lake lab: Cephalon, which is based in Frazer, Pa., but continues to operate a Salt Lake City laboratory, has reported 129 deaths associated with Actiq since it debuted in 1999. The company says 36 were tied to overdoses or other misuse. The remaining 91 deaths, which the company says occurred in clinical studies prior to the drug’s launch, were primarily because of cancer.

Still, Connecticut state and Philadelphia federal investigators are looking into Cephalon’s alleged off-label marketing of Actiq and other drugs. Company spokeswoman Sheryl Williams says Cephalon is cooperating with investigators, but insists the company’s representatives stress appropriate use for Actiq. No charges have been filed.

“Our sales force is focused on visiting physicians who are experienced in treatment of cancer pain - and that group is broader than” cancer specialists, adds Williams, whose company has seen sales of Actiq grow from $15 million in 2000 to more than $400 million today, according to The Journal report. Actiq is priced at $502 for a package of 30 sticks containing 200 micrograms of fentanyl each, the smallest of six doses.

The report in The Journal pointed to a survey by research firm ImpactRx, showing that visits by Cephalon sales representatives to noncancer doctors to pitch Actiq increased sixfold from 2002 to 2005. These doctors reported more than 300 visits in 2004 and 2005. Cephalon says it can’t confirm the numbers but it doesn’t dispute that it has stepped up its marketing of Actiq to various types of doctors, ranging from sports-medicine specialists to family practitioners.

Prescribing off-label is a common practice, leaving physicians the final authorities on whether certain drugs intended for specific ailments also can benefit patients diagnosed with other problems. A recent Archives of Internal Medicine study estimates that 20 percent of prescriptions are for off-label uses.

“You don’t want to get to where these drugs are so tightly controlled that physicians are afraid to use them. Then, people who need it most will suffer,” says Mark Fotheringham, spokesman for the Utah Medical Association.

When it comes to Actiq, Bradford Hare, a pharmacologist and senior member of the University of Utah Pain Management Center, agrees - to a point.

“There are very few valid applications” for off-label use of Actiq, he says. “There may be certain clinical situations, for short intense periods of pain, but [Actiq’s] effects are too intense and too short-lived to really be of use for long-term, chronic pain.”

Patients have been referred to Hare who are taking several Actiq doses a day, but he immediately stops that. “It can put patients on a roller coaster,” he says, expressing preference for more conventional, longer-lasting pain medications.

Do I Have An Actiq Lawsuit?

If you or a loved one have taken Actiq and become addicted to the drug or suffered from any serious side effects, you should contact us immediately. You may be entitled to compensation and we can help.

Free Confidential Case Evaluation >>> Actiq Lawsuit

Taken improperly, drug can overwhelm users

Bookmark | Live Chat

Link to Article: Taken improperly, drug can overwhelm users

Posted in: Actiq

Source | The Daily Item

Considered a life-saver to those battling chronic pain, such as that caused by Lyme disease, fentanyl has long been deemed a reliable source of strength and comfort.

As a potent, short-acting analgesic, fentanyl is commonly prescribed to cancer and surgical patients. It has similar effects as heroin and is considered 80 to 100 times more potent than morphine.

But there is a growing dark side of fentanyl, where people are abusing its potency to obtain a new state-of-the-art high. The growing trend, most notable in the Midwest and portions of Pennsylvania and New Jersey, has health officials concerned.

“Fentanyl can be very rapid acting, so the onset of the effects if used inappropriately can take people by surprise,” said Dean Parry, director of pharmacy and therapeutic services for Geisinger Health System. “When given by injection, the analgesic and other effects may begin to occur within seconds. Oral forms take only a few minutes.”

Medically, fentanyl is used intravenously as an anesthetic (Sublimaze), as a potent analgesic in the form of a transdermal patch (Duragesic), or as the newer lollypop formulation (Actiq) — sold on the street as “Perc-O-Pops.”

Being classified as a schedule II narcotic, fentanyl has a high abuse potential along with a high risk of addiction, according to Jamie Dodson, director of pharmacy services at Sunbury Community Hospital and Outpatient Center.

“It is available in many formulations, including solution for injection, lozenge and patch,” Ms. Dodson said. “If fentanyl is misused, it can cause severe breathing problems, unconsciousness or even death.

“The most common abuse that I am aware of involves misuses of the fentanyl patch. Using more patches than prescribed, using someone else’s patches, applying the patch incorrectly and tampering with the patch can lead to an overdose situation.”

Drug users have been creative in finding new methods of obtaining fentanyl, even resorting to reusing disposed patches found in the garbage.

“When the patch is removed, there is a significant amount of fentanyl still remaining in the patch,” Mr. Parry said. “If it is not disposed of properly, there is the risk of someone getting a hold of the used patches and extracting the fentanyl containing substance.”

The Dumpster-diving and garbage-digging trend has patients taking added precaution with their transdermal patches.

“There needs to be care and consideration when disposing of the used medication patch,” said Peggy Kopitsky, a registered nurse and nurse manager of the emergency department at Bloomsburg Hospital. “(The patches) cannot just be tossed in the garbage can. They should be folded in half and flushed down the toilet.”

Fentanyl abusers have discovered a multitude of ways to get high, especially in an effort to avoid detection by authorities. Drug enforcement agencies have even discovered certain mixes of powder heroin laced with fentanyl.

“Users get quite creative when using fentanyl,” said JoAnn Sassani, a certified registered nurse anesthetist and nurse manager of anesthesiology and same-day surgery at Shamokin Area Community Hospital. “Some inject it under their fingernails, so needle marks are not visible.”

According to Darlene Rowe, director of emergency services at Evangelical Community Hospital, Lewisburg, some users are now chewing patches to extract the fentanyl.

Other identified forms of abuse with the transdermal patches include being snorted and smoked, according to Randy Strausser, director of pharmacy services at Evangelical.

“Fentanyl is extremely dangerous for two reasons,” Mr. Strausser said. “One is because of its potency. Perhaps, more importantly, because it is almost impossible to determine how much of the actual fentanyl is being ingested.”

Competing with the unknown is also a challenge for law enforcement and health officials in their attempt to identify trends in fentanyl abuse.

“Fentanyl does not show up on the routine toxicology screen that is done for a suspected overdose,” said Mr. Parry of the Geisinger Health System. “It has to be requested separately, which means if someone shows up at an emergency room with a fentanyl overdose, it may not be detected right away.”

Do I Have An Actiq Lawsuit?

If you or a loved one have taken Actiq and become addicted to the drug or suffered from any serious side effects, you should contact us immediately. You may be entitled to compensation and we can help.

Free Confidential Case Evaluation >>> Click Here: Actiq Attorney

Actiq Blamed in Student’s Death

Bookmark | Live Chat

Link to Article: Actiq Blamed in Student’s Death

Posted in: Actiq

Source | The Dallas Morning News

Lollipop drug for cancer patients can be a fatal high; abuse on rise …

A rare and expensive painkiller sometimes taken in the form of a lollipop contributed to the death of a 20-year-old Southern Methodist University student at his fraternity house earlier this month.

The Dallas County medical examiner has determined that Jacob Stiles, a sophomore economics and psychology major from Naperville, Ill., accidentally overdosed on a toxic mixture of cocaine, alcohol and the synthetic opiate fentanyl.

Fellow students found him unconscious the afternoon of Dec. 2 in his room at the Sigma Alpha Epsilon fraternity house.

In any form, fentanyl can be lethal if taken outside a prescription, experts say.

“People have died with needles in their arms,” said Kurt Klein- schmidt, an associate professor of emergency medicine at UT Southwestern Medical Center and a toxicologist with the North Texas Poison Center.

“What’s really nasty about fentanyl [is] it’s a more potent narcotic than heroin or morphine – up to 100 times,” Dr. Klein- schmidt said. “People can have overdoses and not know what they’ve gotten themselves into.”

Fentanyl has been linked in the last few years to hundreds of overdose deaths around the country, with hot spots arising in states such as Michigan, Florida and Illinois, where Mr. Stiles is from. While no rash of deaths has been reported in North Texas, Dallas police in the last month busted two employees at a doctor’s office on charges of forging prescriptions for $40,000 worth of the lollipops.

The lollipop form is designed for cancer patients who have trouble swallowing, although experts say more abusers prefer fentanyl patches. Some people apply more than one patch, while more hard-core users use a syringe to extract the drug from the patch.

Local, state and federal officials say that abuse of fentanyl is on the rise, but the fact that it is expensive and hard to get have kept it from spreading more quickly. Abuse is relatively rare, mostly because of the high cost – a lollipop might cost $30 to $40 on the street, while a rock of crack cocaine can sell for a few dollars.

Jeffrey Barnard, Dallas County’s chief medical examiner, said Wednesday that he didn’t know what form of the drug Mr. Stiles took or where he got it.

“We have no known history that he was prescribed fentanyl,” Dr. Barnard said. “His family didn’t return our calls, and his doctor in Illinois gave us no information.”

Mr. Stiles’ family could not be reached for comment.

His fraternity threw a large party off campus the night before Mr. Stiles was found unconscious, but SMU police have not released any information about his activities before the overdose or how he may have obtained or taken the drugs. SMU police did not return phone calls.

“We are deeply saddened by this news,” said Jim Caswell, SMU’s vice president for student affairs. He has no information of anyone else caught abusing fentanyl on campus.

“Our time and effort on drug and alcohol programs are geared constantly toward keeping our students well informed,” he said. “We don’t have our heads in the sand that there are drug and alcohol problems among young people.”

Insurer raises red flag

While Dallas police say they’ve not been overrun with cases of fentanyl abuse, the two recent arrests have put them on notice of the drug’s potential for abuse.

About a month ago, a health insurance company alerted Dallas police to some suspiciously large prescription orders billed to their company for Actiq, which is fentanyl in a berry-flavored lozenge attached to a stick.

Known by abusers as “perc-o-pops” or “lollipops,” they can plunge users into a stupor, severely slow breathing and lead to death.

Dallas police eventually traced the large Actiq order – more than 1,000 lollipops – to two workers at a doctor’s office. They were arrested on suspicion of prescription forgery.

Deputy Police Chief Julian Bernal, who heads the narcotics division, declined to name the employees or where they work because others are expected to be arrested and police do not want to tip off their associates.

Chief Bernal said that the employees used some of the lollipops themselves. “We’re still investigating how the rest were either used or distributed,” he said.

He said he had no information that the two are connected to Mr. Stiles. He said that other than the SMU student, he had heard of no local overdose deaths associated with illegal use of fentanyl.

“It’s extremely unusual to come across this product, because it’s very difficult to obtain, even with a prescription,” he said.

100 Detroit-area deaths

Nationally, fentanyl has been tied to hundreds of fatal and nonfatal overdoses on the East Coast and in the Midwest since late 2005, according to the U.S. Department of Justice. In those cases, fentanyl was produced illegally and often mixed with cocaine or, more often, in heroin in a combination known on the street as “magic.”

Detroit has emerged as ground zero of the growing problem. “Since over a year ago, we’ve had over 100 deaths here,” said Mark Greenwald, a researcher at Wayne State University who is studying fentanyl deaths in the Detroit area.

“To my knowledge, virtually all have been among individuals who have been identified as having a heroin abuse history.” And, Dr. Greenwald said, “Almost all of those deaths among heroin abusers are due to fentanyl that they obtained on the street.”

In 2004, there were an estimated 8,000 emergency-room visits for fentanyl overdoses, according to a survey by the federal Substance Abuse and Mental Health Services Administration. But that’s a fraction compared with other painkillers such as hydrocodone (42,491 visits), oxycodone (36,559 visits) and methadone (31,874 visits).

Rare so far in Texas

In Texas, fentanyl-related deaths are rare, according to Jane Carlisle Maxwell, a University of Texas researcher who compiles an annual report, “Substance Abuse Trends in Texas.”

“We’ve been lucky here,” Dr. Maxwell said. “It’s not the largest problem, but people need to be aware of it.”

Texas reported fentanyl-related deaths in the single digits each year from 1998 to 2001. In 2004, the state recorded 32 deaths, with the victims’ average age at 37. Preliminary figures for 2005 indicate 30 deaths, with an average age of 43.

“In comparison to Vicodin and those other drugs, fentanyl’s a pretty small part of the pie,” Dr. Maxwell said.

To date, little is known about fentanyl use among college students, according to Carol Boyd, a researcher at the University of Michigan Substance Abuse Research Center. Studies have found an increase in the last decade of college students abusing prescription pain medicine such as oxycodone, which includes the brand OxyContin, and hydrocodone, or Vicodin, she said.

One study by Dr. Boyd and her Michigan colleagues found that 7 percent of college students reported nonmedical use of prescription pain relievers in the last year. College students who were white, lived in fraternity or sorority houses, were at more competitive colleges and had lower grade-point averages tended to report greater use. The study said results show that prescription drug abuse “represents a problem on college campuses.”

Research also shows that college students who take those drugs for nonmedical uses tended to use alcohol at the same time.

Dr. Caswell said that SMU takes a tough stance when students are caught using illegal drugs.

“We have suspended students on our campus for use of cocaine,” he said. “We have a two-strike approach for marijuana. We work very hard to inform our students about what the consequences are for this behavior. Some students come here with these problems.”

He said that no sanctions are planned for the local Sigma Alpha Epsilon fraternity.

“We believe this is isolated and not a chapter-wide problem,” Dr. Caswell said. “It’s resolved to our satisfaction.”

A spokesman at the SAE national office in Chicago said the office’s inquiry into Mr. Stiles death, conducted in concert with an insurance investigator, is continuing. Preliminarily, they do not believe the chapter is involved.

“If the situation were that it was a chapter-wide activity, there would be that possibility” of reprimand, said Tim Samp, an SAE spokesman in Chicago.

Do I Have An Actiq Lawsuit?

If you or a loved one have taken Actiq and become addicted to the drug or suffered from any serious side effects, you should contact us immediately. You may be entitled to compensation and we can help.

Free Confidential Case Evaluation >>> Click Here: Actiq Side Effects

Actiq (Fentanyl) More Potent Than Morphine and Higly Addictive

Bookmark | Live Chat

Link to Article: Actiq (Fentanyl) More Potent Than Morphine and Higly Addictive

Posted in: Actiq

What is fentanyl? A man-made opiate designed as a painkiller. It can be 80 to 100 times more potent than morphine.

How is it taken? The drug comes in the form of a lollipop (for patients who have trouble swallowing) or a patch or can be injected.

Who is it prescribed for? The lollipop form is designed specifically for cancer patients with a high tolerance for morphine. Doctors must be extremely vigilant about dosage and reaction because of its toxicity and addictive properties.

How is it abused? People most often obtain it through forged prescriptions or buy it or steal it from people with legitimate prescriptions. Taken in any of its forms, it is highly addictive and can lower blood pressure and slow breathing to dangerous levels. The high it offers is similar to heroin. Combined with heroin, it has the street name “magic.” Taken with other drugs, it can be fatal.

What Can You Do I How Can We Help? If you or a loved one have taken Actiq and become addicted to the drug or suffered from any serious side effects, you should contact us immediately. You may be entitled to compensation and we can help.

Free Confidential Case Evaluation >>> Click Here: Actiq Addiction

Lollipop drug hitting the streets

Bookmark | Live Chat

Link to Article: Lollipop drug hitting the streets

Posted in: Actiq

Source | CNN (2004)

HARRISBURG, Pennsylvania — A narcotic painkiller that looks like a lollipop — designed to speed relief to cancer patients — is starting to show up in illegal sales with the nickname “perc-a-pop.”

The drug’s ease of use and sweet taste have law enforcement officials worried about the potential for abuse. Actiq, a berry-flavored lozenge on a stick, contains the synthetic opioid fentanyl.

“We’re starting to see it emerge as a drug that is, as we call it, ‘diverted,’ which is a legally prescribed drug being used illegally,” said Kevin Harley, spokesman for state Attorney General Jerry Pappert.

“It’s a drug that is easily administered or taken by somebody who might be afraid to either take a pill, snort or inject a needle in their arm.”

The attractive taste — described by the manufacturer as a “mild berry flavor” — makes abuse more likely, he added. Harley said each Actiq lozenge retails for $9.10. The street value of a perc-a-pop is $20.

“We started seeing them in Philly, and that’s where we understand the nickname came from,” he said.

Manufactured by Cephalon Inc., Actiq’s active ingredient is absorbed by rubbing the lozenge against the inside of the cheek.

It is approved by the Food and Drug Administration to combat “breakthrough pain,” flare-ups suffered by cancer patients who are already taking narcotics in more conventional liquid or pill form to cope with chronic pain.

“Like any opioid, there is a potential for misuse,” said company spokeswoman Stacey Backhardt. She said the company believes, however, “there has not been a substantial diversion of this product in the state or elsewhere.”

Fentanyl was first introduced as an intravenous anesthetic called Sublimaze in the 1960s. Besides being taken orally, it is also dispensed as a transdermal patch under the trade name Duragesic.

Hospitals in the lower 48 states reported 576 incidents of non-medical use of fentanyl products in 2000; the number rose to 1,506 by 2002, said Leah R. Young, spokeswoman for the federal Substance Abuse and Mental Health Services Administration.

 

Free Confidential Case Evaluation

Toll Free 24 hrs/day (866) 588-0600

Secure 128-bit SSL Encrypted Email Communication Secure 128-bit SSL Encrypted Email Communication - Click Here.

Secure 128-bit SSL Encrypted Email Communication Secure 1024-bit SSL Encrypted Live Chat Communication - Click Here.

Fields Marked with * are required= Required Field

Toll Free (866) 588-0600

People Over Profits - Attorney, Lawyer Group

American Association for Justice - Trial Lawyer Group

Peer Review Rated Attorneys and Lawyers

 

 

ATLA Attorney, Atla Lawyer